informaworld logo
HOME . ABOUT US . CONTACT US 		HELP . PUBLISH WITH US . LIBRARIANS 
ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Volume 49 Issue 5       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Leukemia and Lymphoma, Volume 49 Issue 5 2008

Leukemia and Lymphoma is moving!
2008 Impact Factor: 1.939 (© Thomson Reuters, Journal Citation Reports®, 2009)
ISSN: 1029-2403 (electronic) 1042-8194 (paper)
Publication Frequency: 12 issues per year
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2 • Next >
View new articles ahead of the print edition
select-down Click for help
Commentaries
Current therapy of myeloma induced renal failure
Morie A. Gertz
Pages 833 – 834
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Stem cell transplant for chronic lymphocytic leukemia/small lymphocytic lymphoma
William J. Hogan; Clive S. Zent
Pages 835 – 836
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Targeting the follicular lymphoma microenvironment – Ready for prime-time?
Matthew C. Cheung; Kevin R. Imrie
Pages 837 – 838
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Minimizing late effects in children and adults with Hodgkin lymphoma – The beginning of the end for radiation therapy
John W. Sweetenham
Pages 839 – 840
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Non-Hodgkins lymphoma: How well you do may depend on where you live
Raymond D. Massenburg;  Joe Feinglass; Charles Bennett
Pages 841 – 842
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Host immunity and survival
Luis F. Porrata
Pages 843 – 844
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
T/B and not T/B: High frequency of B-cell dyscrasias in T-LGL leukemia
Attaphol Pawarode; Maria Baer
Pages 845 – 846
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Ikaros and acute leukemia
Charles Mullighan; James Downing
Pages 847 – 849
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Sphingosine kinase is an attractive target for novel pharmacological interventions in non-Hodgkin lymphomas
Shahab Uddin; Leonidas C. Platanias
Pages 850 – 851
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Reviews
Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens
Keith Pratz; Mark Levis
Pages 852 – 863
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Molecular diagnostics in chronic lymphocytic leukemia – Pathogenetic and clinical implications
Thorsten Zenz;  Daniel Mertens;  Hartmut Döhner; Stephan Stilgenbauer
Pages 864 – 873
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas
Samir Parekh;  Gilbert Privé; Ari Melnick
Pages 874 – 882
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Current role of gemcitabine in the treatment of Hodgkin lymphoma
Yasuhiro Oki; Anas Younes
Pages 883 – 889
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles: Clinical
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens
Maria Roussou;  Efstathios Kastritis;  Magdalini Migkou;  Erasmia Psimenou;  Irini Grapsa;  Charis Matsouka;  Despina Barmparousi;  Evangelos Terpos; Meletios Athanasios Dimopoulos
Pages 890 – 895
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Cited By | Related Articles 		 buy now buy now
Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia
Sarr Gill;  Anoren Grigg;  Jeff Szer; David Ritchie
Pages 896 – 901
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Cited By | Related Articles 		 buy now buy now
Targeting the follicular lymphoma microenvironment through blockade of TNFα with etanercept
Jonathan Friedberg;  Eric Jacobsen;  Donna Neuberg;  Jeffrey Kutok;  Olivier Munoz;  Vassiliki Boussiotis;  Hazel Reynolds;  David Fisher;  Agnieszka Szot;  Annick Van Den Abbeele; Arnold Freedman
Pages 902 – 909
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Cited By | Related Articles 		 buy now buy now
Hodgkin lymphoma in very young children: Clinical characteristics and outcome of treatment
Asim Belgaumi;  Amani Al-Kofide;  Nicey Joseph;  Rubina Jamil-Malik;  Yasser Khafaga; Rajeh Sabbah
Pages 910 – 916
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Socio-economic deprivation and survival of non-Hodgkin lymphoma in Scotland
Caroline Bray;  David S. Morrison; Pam McKay
Pages 917 – 923
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Cited By | Related Articles 		 buy now buy now
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma
Paul L. R. Mitchell;  Paula Marlton;  Andrew Grigg;  John F. Seymour;  Mark Hertzberg;  Arno Enno;  Richard Herrmann;  Rodney Bond; Chris Arthur
Pages 924 – 931
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文（简体和繁體）
© 2009 Informa plc